Silencing CEP192 using siRNAs increased the proportion of cells in the G0/G1 phase and decreased the cell populations in the G2/M phase of the cell cycle, thereby preventing cell cycle progression and arresting tumor cell growth. The gene discussed is CEP192; the disease is neoplasm.